Financhill
Sell
37

BMY Quote, Financials, Valuation and Earnings

Last price:
$47.95
Seasonality move :
0.17%
Day range:
$47.95 - $48.85
52-week range:
$39.35 - $63.33
Dividend yield:
5.09%
P/E ratio:
17.96x
P/S ratio:
2.05x
P/B ratio:
5.61x
Volume:
11.2M
Avg. volume:
16.1M
1-year change:
14.85%
Market cap:
$97.6B
Revenue:
$48.3B
EPS (TTM):
$2.67

Analysts' Opinion

  • Consensus Rating
    Bristol-Myers Squibb has received a consensus rating of Hold. The company's average rating is a Hold based on 3 Buy ratings, 18 Hold ratings, and 1 Sell rating.
  • Price Target Upside
    According to analysts' consensus price target of $57.10, Bristol-Myers Squibb has an estimated upside of 19.07% from its current price of $47.95.
  • Price Target Downside
    According to analysts, the lowest downside price target is $36.00 representing 24.92% downside risk from its current price of $47.95.

Fair Value

  • According to the consensus of 22 analysts, Bristol-Myers Squibb has 19.07% upside to fair value with a price target of $57.10 per share.

BMY vs. S&P 500

  • Over the past 5 trading days, Bristol-Myers Squibb has overperformed the S&P 500 by 1.08% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Bristol-Myers Squibb does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Bristol-Myers Squibb revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Bristol-Myers Squibb reported revenues of $11.2B.

Earnings Growth

  • Bristol-Myers Squibb earnings have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter Bristol-Myers Squibb reported earnings per share of $1.20.
Enterprise value:
135.6B
EV / Invested capital:
2.02x
Price / LTM sales:
2.05x
EV / EBIT:
16.69x
EV / Revenue:
2.85x
PEG ratio (5yr expected):
--
EV / Free cash flow:
10.36x
Price / Operating cash flow:
7.45x
Enterprise value / EBITDA:
8.37x
Gross Profit (TTM):
$33.6B
Return On Assets:
5.74%
Net Income Margin (TTM):
11.38%
Return On Equity:
32.01%
Return On Invested Capital:
7.93%
Operating Margin:
31.22%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-03-31 2024-03-31 2025-03-31 2024-03-31 2025-03-31
Income Statement
Revenue $45.8B $45.5B $47.6B $11.9B $11.2B
Gross Profit $35.6B $34.5B $33.6B $8.9B $8.2B
Operating Income $8.9B $7.3B $7.9B $1.5B $3.5B
EBITDA $20.1B $5.3B $16.2B -$8.6B $4.5B
Diluted EPS $3.43 -$3.10 $2.67 -$5.89 $1.20
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Balance Sheet
Current Assets $27.1B $30.1B $27.1B $28.7B $30.8B
Total Assets $112.4B $103B $94.3B $99B $92.4B
Current Liabilities $17.3B $22.8B $19.1B $25.8B $24.1B
Total Liabilities $74.8B $71.4B $62.4B $82.5B $75B
Total Equity $37.7B $31.6B $31.9B $16.5B $17.4B
Total Debt $46.3B $45B $37.8B $55.7B $49.7B
Trailing 12 Months Fiscal Quarters
Period Ending 2023-03-31 2024-03-31 2025-03-31 2024-03-31 2025-03-31
Cash Flow Statement
Cash Flow Operations $12.2B $13.7B $14.3B $2.8B $2B
Cash From Investing -$1.4B -$21.7B -$2.2B -$19.6B -$499M
Cash From Financing -$14.4B $8.3B -$10.5B $14.6B -$993M
Free Cash Flow $11.1B $12.5B $13.1B $2.6B $1.7B
BMY
Sector
Market Cap
$97.6B
$33.6M
Price % of 52-Week High
75.72%
45.68%
Dividend Yield
5.09%
0%
Shareholder Yield
2.14%
-0.66%
1-Year Price Total Return
14.85%
-38.85%
Beta (5-Year)
0.378
0.633
Dividend yield:
5.09%
Annualized payout:
$2.40
Payout ratio:
90.59%
Growth streak:
3 years

Technicals

8-day SMA
Buy
Level $47.71
200-day SMA
Sell
Level $54.16
Bollinger Bands (100)
Sell
Level 49.2 - 59.62
Chaikin Money Flow
Buy
Level 2.1B
20-day SMA
Buy
Level $47.16
Relative Strength Index (RSI14)
Sell
Level 47.75
ADX Line
Sell
Level 27.13
Williams %R
Neutral
Level -21.7295
50-day SMA
Sell
Level $50.53
MACD (12, 26)
Sell
Level -0.56
25-day Aroon Oscillator
Sell
Level -32
On Balance Volume
Neutral
Level 1.3B

Financial Scores

Sell
Altman Z-Score (Annual)
Level (1.4991)
Sell
CA Score (Annual)
Level (-1.7489)
Buy
Beneish M-Score (Annual)
Level (-3.72)
Buy
Momentum Score
Level (8)
Buy
Ohlson Score
Level (-0.0559)
Buy
Piotroski F Score (Annual)
Level (4)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (7)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

Stock Forecast FAQ

In the current month, BMY has received 3 Buy ratings 18 Hold ratings, and 1 Sell ratings. The BMY average analyst price target in the past 3 months is $57.10.

  • Where Will Bristol-Myers Squibb Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Bristol-Myers Squibb share price will rise to $57.10 per share over the next 12 months.

  • What Do Analysts Say About Bristol-Myers Squibb?

    Analysts are divided on their view about Bristol-Myers Squibb share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Bristol-Myers Squibb is a Sell and believe this share price will drop from its current level to $36.00.

  • What Is Bristol-Myers Squibb's Price Target?

    The price target for Bristol-Myers Squibb over the next 1-year time period is forecast to be $57.10 according to 22 Wall Street analysts, 3 of them rate the stock a Buy, 1 rates the stock a Sell, and 18 analysts rate the stock a Hold.

  • Is BMY A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Bristol-Myers Squibb is a Hold. 18 of 22 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of BMY?

    You can purchase shares of Bristol-Myers Squibb via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Bristol-Myers Squibb shares.

  • What Is The Bristol-Myers Squibb Share Price Today?

    Bristol-Myers Squibb was last trading at $47.95 per share. This represents the most recent stock quote for Bristol-Myers Squibb. Yesterday, Bristol-Myers Squibb closed at $47.95 per share.

  • How To Buy Bristol-Myers Squibb Stock Online?

    In order to purchase Bristol-Myers Squibb stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is It Time to Sell MercadoLibre?
Is It Time to Sell MercadoLibre?

MercadoLibre (NASDAQ:MELI) has earned a reputation for being not dissimilar…

Is Tesla Stock High Risk or High Reward?
Is Tesla Stock High Risk or High Reward?

EV-making supergiant Tesla, Inc. (NASDAQ:TSLA) is going through a difficult…

Why Did Chase Coleman Buy TSM?
Why Did Chase Coleman Buy TSM?

Billionaire Chase Coleman of Tiger Global Management has built a…

Stock Ideas

Buy
65
Is NVDA Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 48x

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Sell
42
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Buy
80
GWRE alert for Jun 5

Guidewire Software [GWRE] is up 0.24% over the past day.

Buy
60
REVG alert for Jun 5

REV Group [REVG] is up 0.37% over the past day.

Buy
55
SIG alert for Jun 5

Signet Jewelers [SIG] is down 0.38% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock